Hyeunkil Shin

Title: Hyeunkil Shin: Innovator in Probiotic Strains

Introduction

Hyeunkil Shin is a notable inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of probiotics, particularly in developing strains that have anti-inflammatory and metabolic disease alleviating properties. His work has the potential to impact health food compositions and therapeutic applications.

Latest Patents

Hyeunkil Shin holds a patent for the HAC01 strain, which is recognized for its anti-inflammatory efficacy and its ability to alleviate metabolic diseases. The patent details a probiotic preparation, an anti-inflammatory composition, and a health food composition that includes the HAC01 strain or its derivatives as active ingredients. This innovation represents a significant advancement in the use of probiotics for health improvement.

Career Highlights

Throughout his career, Hyeunkil Shin has worked with various organizations, including Atogen Co., Ltd and the Handong Global University Industry-Academic Cooperation Foundation. His experience in these institutions has allowed him to further his research and development in the field of probiotics.

Collaborations

Hyeunkil Shin has collaborated with notable individuals in his field, including Wilhelm Holzapfel and Chang-kee Hyun. These collaborations have contributed to the advancement of his research and the successful development of his patented strain.

Conclusion

Hyeunkil Shin's innovative work in probiotic strains showcases his commitment to improving health through scientific research. His contributions are paving the way for new health solutions and enhancing our understanding of metabolic diseases.